Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort studyResearch in context
Summary: Background: Assessment of cardiovascular risk is critical for patients with cancer. Previous retrospective studies suggest potential cardiotoxicity of CAR T cell therapies. We aimed to prospectively assess cardiotoxicity and the predictive value of cardiac biomarkers and classical risk fac...
Những tác giả chính: | , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2024-03-01
|
Loạt: | EClinicalMedicine |
Những chủ đề: | |
Truy cập trực tuyến: | http://www.sciencedirect.com/science/article/pii/S258953702400083X |